|
ATC |
1 Agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
|
|
4 Agents affecting cellular function
|
41 Cellular function activating agents
|
42 Antineoplastics
|
421 Alkylating agents
|
422 Antimetabolites
|
423 Antibiotics
|
424 Plant extract preparations
|
429 Miscellaneous
|
4291 Other Antitumors
|
D00068 Alcohol (USP); Anhydrous ethanol (JP17)
D00094 Tretinoin (JAN/USP/INN)
D01370 Cladribine (JAN/USAN/INN)
D03021 Azacitidine (JAN/USAN/INN)
D06199 Trabectedin (JAN/USAN/INN)
D02166 Mitoxantrone hydrochloride (JAN/USP)
D00275 Cisplatin (JP17/USP/INN)
D01363 Carboplatin (JP17/USP/INN)
D01790 Oxaliplatin (JAN/USAN/INN)
D00478 Procarbazine hydrochloride (JP17/USP)
D02994 Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN)
D03257 Trastuzumab (INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN)
D03455 Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN)
D06409 Bevacizumab (USAN); Bevacizumab (genetical recombination) (JAN)
D05350 Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN)
D09314 Ofatumumab (USAN/INN); Ofatumumab (genetical recombination) (JAN)
D04603 Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN)
D09587 Brentuximab vedotin (USAN); Brentuximab vedotin (genetical recombination) (JAN)
D05446 Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN)
D09980 Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN)
D10316 Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN)
D10574 Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN)
D09371 Ramucirumab (USAN); Ramucirumab (genetical recombination) (JAN)
D09337 Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN)
D10777 Daratumumab (USAN); Daratumumab (genetical recombination) (JAN)
D09761 Mogamulizumab (USAN); Mogamulizumab (genetical recombination) (JAN)
D01441 Imatinib mesylate (USAN); Imatinib mesilate (JAN)
D01977 Gefitinib (JAN/USAN/INN)
D04023 Erlotinib hydrochloride (JAN/USAN)
D06402 Sunitinib malate (JAN/USAN)
D06272 Sorafenib tosylate (USAN); Sorafenib tosilate (JAN)
D06414 Dasatinib (USAN); Dasatinib hydrate (JAN)
D04024 Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)
D06413 Nilotinib hydrochloride hydrate (JAN)
D06068 Temsirolimus (JAN/USAN/INN)
D02714 Everolimus (JAN/USAN/INN)
D05380 Pazopanib hydrochloride (JAN/USAN)
D06407 Vandetanib (JAN/USAN/INN)
D09733 Afatinib dimaleate (USAN); Afatinib maleate (JAN)
D09728 Bosutinib hydrate (JAN)
D09996 Vemurafenib (JAN/USAN/INN)
D09731 Crizotinib (JAN/USAN/INN)
D03218 Axitinib (JAN/USAN)
D09960 Ruxolitinib phosphate (JAN/USAN)
D10137 Regorafenib hydrate (JAN)
D10104 Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN)
D09951 Ponatinib hydrochloride (JAN/USAN)
D10176 Trametinib dimethyl sulfoxide (JAN/USAN)
D10223 Ibrutinib (JAN/USAN)
D10551 Ceritinib (JAN/USAN/INN)
D09920 Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN)
D10372 Palbociclib (JAN/USAN)
D10766 Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)
D10450 Alectinib hydrochloride (JAN)
D02997 Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN)
D00155 Pentostatin (JAN/USAN/INN)
D03106 Bexarotene (JAN/USAN/INN)
D02106 Arsenic trioxide (JP17/USAN)
D03150 Bortezomib (JAN/USAN/INN)
D06320 Vorinostat (JAN/USAN)
D06637 Romidepsin (JAN/USAN/INN)
D08914 Eribulin mesylate (USAN); Eribulin mesilate (JAN)
D10019 Panobinostat lactate (JAN)
D08880 Carfilzomib (JAN/USAN/INN)
D09730 Olaparib (JAN/USAN/INN)
D10131 Ixazomib citrate (JAN/USAN)
D00966 Tamoxifen citrate (JP17/USP)
D00967 Toremifene citrate (JAN/USAN)
D01161 Fulvestrant (JAN/USAN/INN)
D00586 Flutamide (JP17/USP/INN)
D00961 Bicalutamide (JAN/USP/INN)
D10218 Enzalutamide (JAN/USAN)
D00960 Anastrozole (JAN/USAN/INN)
D00964 Letrozole (JAN/USP/INN)
D00963 Exemestane (JAN/USP/INN)
D09701 Abiraterone acetate (JAN/USAN)
D00753 Sirolimus (JAN/USAN/INN)
D02802 Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN)
D00754 Thalidomide (JAN/USP/INN)
D09813 Lenalidomide hydrate (JAN)
D08976 Pomalidomide (JAN/USAN/INN)
D04489 Ibritumomab tiuxetan (USAN/INN); Ibritumomab tiuxetan (genetical recombination) (JAN)
D10398 Radium-223 dichloride (USAN)
D01404 Sobuzoxane (JAN)
D01416 Nedaplatin (JAN/INN)
D01418 Tamibarotene (JAN/INN)
D04245 Forodesine hydrochloride (JAN/USAN)
D06294 Miriplatin hydrate (JAN)
D10773 Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN)
D10817 Avelumab (USAN); Avelumab (genetical recombination) (JAN)
D10819 Aflibercept beta (genetical recombination) (JAN)
|
D08AX08 V03AB16 V03AZ01
D10AD01 L01XX14
L01BB04
L01BC07
L01CX01
L01DB07
L01XA01
L01XA02
L01XA03
L01XB01
L01XC02
L01XC03
L01XC06
L01XC07
L01XC08
L01XC10
L01XC11
L01XC12
L01XC13
L01XC14
L01XC17
L01XC18
L01XC21
L01XC23
L01XC24
L01XC25
L01XE01
L01XE02
L01XE03
L01XE04
L01XE05
L01XE06
L01XE07
L01XE08
L01XE09
L01XE10 L04AA18
L01XE11
L01XE12
L01XE13
L01XE14
L01XE15
L01XE16
L01XE17
L01XE18
L01XE21
L01XE23
L01XE24
L01XE25
L01XE27
L01XE28
L01XE29
L01XE33
L01XE35
L01XE36
L01XX02
L01XX08
L01XX25
L01XX27
L01XX32
L01XX38
L01XX39
L01XX41
L01XX42
L01XX45
L01XX46
L01XX50
L02BA01
L02BA02
L02BA03
L02BB01
L02BB03
L02BB04
L02BG03
L02BG04
L02BG06
L02BX03
L04AA10 S01XA23
L04AA34
L04AX02
L04AX04
L04AX06
V10XX02
V10XX03
|
4299 Others
|
43 Radioactive drugs
|
44 Allergic agents
|
49 Other agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|